These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24405192)

  • 1. Founder mutation for Huntington disease in Caucasus Jews.
    Melamed O; Behar DM; Bram C; Magal N; Pras E; Reznik-Wolf H; Borochowitz ZU; Davidov B; Mor-Cohen R; Baris HN
    Clin Genet; 2015 Feb; 87(2):167-72. PubMed ID: 24405192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Ethnic Clusters with Huntington Disease in Israel: The Case of Mountain Jews and Karaites.
    Zitser J; Thaler A; Inbar N; Gad A; Faust-Socher A; Paleacu D; Anca-Herschkovitch M; Balash Y; Shabtai H; Ash EL; Merkin L; Manor Y; Kestenbaum M; Bar David A; Peretz C; Naiman T; Bar-Shira A; Orr-Urtreger A; Dangoor N; Giladi N; Gurevich T
    Neurodegener Dis; 2017; 17(6):281-285. PubMed ID: 28848105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.
    Krause A; Mitchell C; Essop F; Tager S; Temlett J; Stevanin G; Ross C; Rudnicki D; Margolis R
    Am J Med Genet B Neuropsychiatr Genet; 2015 Oct; 168(7):573-85. PubMed ID: 26079385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes.
    Baine FK; Kay C; Ketelaar ME; Collins JA; Semaka A; Doty CN; Krause A; Greenberg LJ; Hayden MR
    Eur J Hum Genet; 2013 Oct; 21(10):1120-7. PubMed ID: 23463025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy?
    Herishanu YO; Parvari R; Pollack Y; Shelef I; Marom B; Martino T; Cannella M; Squitieri F
    J Neurol Sci; 2009 Feb; 277(1-2):143-6. PubMed ID: 19059613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-Level Analysis of the Major European Huntington Disease Haplotype.
    Lee JM; Kim KH; Shin A; Chao MJ; Abu Elneel K; Gillis T; Mysore JS; Kaye JA; Zahed H; Kratter IH; Daub AC; Finkbeiner S; Li H; Roach JC; Goodman N; Hood L; Myers RH; MacDonald ME; Gusella JF
    Am J Hum Genet; 2015 Sep; 97(3):435-44. PubMed ID: 26320893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ancient origin of the CAG expansion causing Huntington disease in a Spanish population.
    García-Planells J; Burguera JA; Solís P; Millán JM; Ginestar D; Palau F; Espinós C
    Hum Mutat; 2005 May; 25(5):453-9. PubMed ID: 15832309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.
    Warby SC; Visscher H; Collins JA; Doty CN; Carter C; Butland SL; Hayden AR; Kanazawa I; Ross CJ; Hayden MR
    Eur J Hum Genet; 2011 May; 19(5):561-6. PubMed ID: 21248742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biallelic mutations in huntington disease: A new case with just one affected parent, review of the literature and terminology.
    Uhlmann WR; Peñaherrera MS; Robinson WP; Milunsky JM; Nicholson JM; Albin RL
    Am J Med Genet A; 2015 May; 167A(5):1152-60. PubMed ID: 25736541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America.
    Kay C; Tirado-Hurtado I; Cornejo-Olivas M; Collins JA; Wright G; Inca-Martinez M; Veliz-Otani D; Ketelaar ME; Slama RA; Ross CJ; Mazzetti P; Hayden MR
    Eur J Hum Genet; 2017 Feb; 25(3):332-340. PubMed ID: 28000697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population.
    Kay C; Collins JA; Wright GEB; Baine F; Miedzybrodzka Z; Aminkeng F; Semaka AJ; McDonald C; Davidson M; Madore SJ; Gordon ES; Gerry NP; Cornejo-Olivas M; Squitieri F; Tishkoff S; Greenberg JL; Krause A; Hayden MR
    Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):346-357. PubMed ID: 29460498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup.
    Warby SC; Montpetit A; Hayden AR; Carroll JB; Butland SL; Visscher H; Collins JA; Semaka A; Hudson TJ; Hayden MR
    Am J Hum Genet; 2009 Mar; 84(3):351-66. PubMed ID: 19249009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population.
    Ma M; Yang Y; Shang H; Su D; Zhang H; Ma Y; Liu Y; Tao D; Zhang S
    J Neurol Sci; 2010 Nov; 298(1-2):57-60. PubMed ID: 20864123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry.
    Kay C; Collins JA; Skotte NH; Southwell AL; Warby SC; Caron NS; Doty CN; Nguyen B; Griguoli A; Ross CJ; Squitieri F; Hayden MR
    Mol Ther; 2015 Nov; 23(11):1759-1771. PubMed ID: 26201449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease.
    Maat-Kievit A; Helderman-van den Enden P; Losekoot M; de Knijff P; Belfroid R; Vegter-van der Vlis M; Roos R; Breuning M
    Am J Med Genet; 2001 Dec; 105(8):737-44. PubMed ID: 11803522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new mutation for Huntington disease following maternal transmission of an intermediate allele.
    Semaka A; Kay C; Belfroid RD; Bijlsma EK; Losekoot M; van Langen IM; van Maarle MC; Oosterloo M; Hayden MR; van Belzen MJ
    Eur J Med Genet; 2015 Jan; 58(1):28-30. PubMed ID: 25464109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease.
    Kay C; Collins JA; Caron NS; Agostinho LA; Findlay-Black H; Casal L; Sumathipala D; Dissanayake VHW; Cornejo-Olivas M; Baine F; Krause A; Greenberg JL; Paiva CLA; Squitieri F; Hayden MR
    Am J Hum Genet; 2019 Dec; 105(6):1112-1125. PubMed ID: 31708117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation.
    Costa MDC; Magalhães P; Guimarães L; Maciel P; Sequeiros J; Sousa A
    J Hum Genet; 2006; 51(3):189-195. PubMed ID: 16372132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington's disease.
    Agostinho Lde A; Rocha CF; Medina-Acosta E; Barboza HN; da Silva AF; Pereira SP; da Silva Idos S; Paradela ER; Figueiredo AL; Nogueira Ede M; Alvarenga RM; Hernan Cabello P; dos Santos SR; Paiva CL
    J Hum Genet; 2012 Dec; 57(12):796-803. PubMed ID: 23051704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of myotonic dystrophy in Israeli Jewish communities: inter-community variation and founder premutations.
    Segel R; Silverstein S; Lerer I; Kahana E; Meir R; Sagi M; Zilber N; Korczyn AD; Shapira Y; Argov Z; Abeliovich D
    Am J Med Genet A; 2003 Jun; 119A(3):273-8. PubMed ID: 12784291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.